Atypical complication in an adult patient with dengue and autoimmune hemolytic anemia: a case report

[1]Srichaikul T, Nimmannitya S. Haematology in dengue and dengue haemorrhagic fever. Baillieres Best Pract Res Clin Haematol. 2000; 13:261–76.SrichaikulTNimmannityaSHaematology in dengue and dengue haemorrhagic feverBaillieres Best Pract Res Clin Haematol2000132617610.1053/beha.2000.007310942625Search in Google Scholar

[2]Chuansumrit A, Wangruangsatid S, Lektrakul Y, Chua MN, Zeta Capeding MR, Bech OM; Dengue Study Group. Control of bleeding in children with Dengue hemorrhagic fever using recombinant activated factor VII: a randomized, double-blind, placebo-controlled study. Blood Coagul Fibrinolysis. 2005; 16:549–55.ChuansumritAWangruangsatidSLektrakulYChuaMNZeta CapedingMRBechOMDengue Study GroupControl of bleeding in children with Dengue hemorrhagic fever using recombinant activated factor VII: a randomized, double-blind, placebo-controlled studyBlood Coagul Fibrinolysis2005165495510.1097/01.mbc.0000186837.78432.2f16269927Search in Google Scholar

[3]Verdeal JC, Costa Filho R, Vanzillotta C, Macedo GL, Bozza FA, Toscano L, et al. Guidelines for the management of patients with severe forms of dengue. Rev Bras Ter Intensiva. 2011; 23:125–33. [Article in English, Portuguese]VerdealJCCosta FilhoRVanzillottaCMacedoGLBozzaFAToscanoLGuidelines for the management of patients with severe forms of dengueRev Bras Ter Intensiva20112312533[Article in English, Portuguese]10.1590/S0103-507X2011000200004Search in Google Scholar

[4]Chamnanchanunt S, Kanagaraj D, Thanachartwet V, Desakorn V, Rojnuckarin P. Early predictors of clinically significant bleeding in adults with dengue infection. Southeast Asian J Trop Med Public Health. 2012; 43:890–9.ChamnanchanuntSKanagarajDThanachartwetVDesakornVRojnuckarinPEarly predictors of clinically significant bleeding in adults with dengue infectionSoutheast Asian J Trop Med Public Health2012438909Search in Google Scholar

[5]Cavalcanti LPdG, Braga DNdM, Pompeu MMdL, Lima AAB, Silva LMAd, Aguiar MG, et al. Evaluation of the World Health Organization 2009 classification of dengue severity in autopsied individuals, during the epidemics of 2011 and 2012 in Brazil. Rev Soc Bras Med Trop. 2015; 48:658–64.CavalcantiLPdGBragaDNdMPompeuMMdLLimaAABSilvaLMAdAguiarMGEvaluation of the World Health Organization 2009 classification of dengue severity in autopsied individuals, during the epidemics of 2011 and 2012 in BrazilRev Soc Bras Med Trop2015486586410.1590/0037-8682-0287-201526676489Search in Google Scholar

[6]Goodnough LT, Lublin DM, Zhang L, Despotis G, Eby C. Transfusion medicine service policies for recombinant factor VIIa administration. Transfusion. 2004; 44:1325–31.GoodnoughLTLublinDMZhangLDespotisGEbyCTransfusion medicine service policies for recombinant factor VIIa administrationTransfusion20044413253110.1111/j.1537-2995.2004.04052.x15318856Search in Google Scholar

[7]Chaudhary RK, Das SS. Autoimmune hemolytic anemia: from lab to bedside. Asian J Transfus Sci. 2014; 8:5–12.ChaudharyRKDasSSAutoimmune hemolytic anemia: from lab to bedsideAsian J Transfus Sci2014851210.4103/0973-6247.126681394314824678166Search in Google Scholar

[8]Dutta TK, Verma SP. Rational use of recombinant factor VIIa in clinical practice. Indian J Hematol Blood Transfus. 2014; 30:85–90.DuttaTKVermaSPRational use of recombinant factor VIIa in clinical practiceIndian J Hematol Blood Transfus201430859010.1007/s12288-013-0240-9402291824839361Search in Google Scholar

[9]Oka S, Shiragami H, Nohgawa M. Intravascular hemolytic anemia in a patient with antibodies related to meropenem. Intern Med. 2015; 54:1291–5.OkaSShiragamiHNohgawaMIntravascular hemolytic anemia in a patient with antibodies related to meropenemIntern Med2015541291510.2169/internalmedicine.54.338525986273Search in Google Scholar

[10]Zanella A, Barcellini W. Treatment of autoimmune hemolytic anemias. Haematologica. 2014; 99:1547–54.ZanellaABarcelliniWTreatment of autoimmune hemolytic anemiasHaematologica20149915475410.3324/haematol.2014.114561418125025271314Search in Google Scholar

[11]Jaime-Peréz JC, Rodríguez-Martínez M, Gómez-de-León A, Tarín-Arzaga L, Gómez-Almaguer D. Current approaches for the treatment of autoimmune hemolytic anemia. Arch Immunol Ther Exp (Warsz). 2013; 61:385–95.Jaime-PerézJCRodríguez-MartínezMGómez-de-LeónATarín-ArzagaLGómez-AlmaguerDCurrent approaches for the treatment of autoimmune hemolytic anemiaArch Immunol Ther Exp (Warsz)2013613859510.1007/s00005-013-0232-323689532Search in Google Scholar

[12]Berentsen S, Tjønnfjord GE. Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia. Blood Rev. 2012; 26:107–15.BerentsenSTjønnfjordGEDiagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemiaBlood Rev2012261071510.1016/j.blre.2012.01.00222330255Search in Google Scholar

[13]King KE, Ness PM. Treatment of autoimmune hemolytic anemia. Semin Hematol. 2005; 42:131–6.KingKENessPMTreatment of autoimmune hemolytic anemiaSemin Hematol200542131610.1053/j.seminhematol.2005.04.00316041662Search in Google Scholar